Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$725K Sell
2,761
-714
-21% -$191K 0.05% 189
2022
Q3
$784K Sell
3,475
-3
-0.1% -$727 0.06% 152
2022
Q2
$847K Buy
3,478
+726
+26% +$178K 0.06% 150
2022
Q1
$666K Buy
+2,752
New +$632K 0.03% 183
2020
Q1
Sell
-8,805
Closed -$2.12M 250
2019
Q4
$2.12M Sell
8,805
-12
-0.1% -$2.65K 0.18% 107
2019
Q3
$1.71M Sell
8,817
-1,211
-12% -$232K 0.15% 111
2019
Q2
$1.85M Sell
10,028
-1,407
-12% -$252K 0.17% 104
2019
Q1
$2.17M Buy
11,435
+13
+0.1% +$2.48K 0.2% 94
2018
Q4
$2.22M Sell
11,422
-3,458
-23% -$675K 0.21% 86
2018
Q3
$3.08M Sell
14,880
-16
-0.1% -$3.15K 0.25% 67
2018
Q2
$2.75M Sell
14,896
-1,563
-9% -$276K 0.26% 71
2018
Q1
$2.81M Buy
16,459
+4,286
+35% +$787K 0.26% 68
2017
Q4
$2.12M Sell
12,173
-793
-6% -$140K 0.22% 75
2017
Q3
$2.42M Buy
12,966
+6,550
+102% +$1.16M 0.33% 52
2017
Q2
$1.1M Buy
6,416
+1,557
+32% +$253K 0.21% 63
2017
Q1
$797K Buy
4,859
+1,153
+31% +$192K 0.16% 74
2016
Q4
$542K Buy
3,706
+2,046
+123% +$308K 0.15% 75
2016
Q3
$264K Buy
+1,660
New +$281K 0.12% 67
2015
Q2
Sell
-1,389
Closed -$222K 50
2015
Q1
$222K Sell
1,389
-82
-6% -$12.9K 0.17% 59
2014
Q4
$234K Buy
+1,471
New +$229K 0.18% 61

Other funds holding AMGN

Zeke Capital Advisors's AMGN Position: Q4 2022 in Review

Zeke Capital Advisors reduced its Amgen (AMGN) stake by 21% in Q4 2022, selling an estimated $191K and leaving 2,761 shares worth $725K. The position accounts for 0.05% of the portfolio, ranked #189.

Zeke Capital Advisors first reported a position in AMGN in Q4 2014 and has held it in 20 quarters since. The position peaked at $3.08M in Q3 2018. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Zeke Capital Advisors held 2,761 shares of Amgen worth $725K as of Q4 2022.
  • Zeke Capital Advisors sold 714 Amgen shares in Q4 2022, an estimated $191K.
  • Amgen made up 0.05% of Zeke Capital Advisors's portfolio in Q4 2022, its #189 holding.
  • Zeke Capital Advisors first reported a position in Amgen in Q4 2014 and has held it in 20 quarters since.
  • Zeke Capital Advisors's Amgen position peaked at $3.08M in Q3 2018.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.